Pulse lineResearch With Heart Logo

ARIC Publications

Filters: First Letter Of Last Name is B  [Clear All Filters]
Journal Article
Gorski M, van der Most PJ, Teumer A, et al. "1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function." Sci Rep. 2017;7:45040.
Gorski M, van der Most PJ, Teumer A, et al. "1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function." Sci Rep. 2017;7:45040.
Gorski M, van der Most PJ, Teumer A, et al. "1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function." Sci Rep. 2017;7:45040.
Gorski M, van der Most PJ, Teumer A, et al. "1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function." Sci Rep. 2017;7:45040.
Gorski M, van der Most PJ, Teumer A, et al. "1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function." Sci Rep. 2017;7:45040.
Gorski M, van der Most PJ, Teumer A, et al. "1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function." Sci Rep. 2017;7:45040.
Adib-Samii P, Rost N, Traylor M, et al. "17q25 Locus is associated with white matter hyperintensity volume in ischemic stroke, but not with lacunar stroke status." Stroke. 2013;44(6):1609-15.
Adib-Samii P, Rost N, Traylor M, et al. "17q25 Locus is associated with white matter hyperintensity volume in ischemic stroke, but not with lacunar stroke status." Stroke. 2013;44(6):1609-15.
Adib-Samii P, Rost N, Traylor M, et al. "17q25 Locus is associated with white matter hyperintensity volume in ischemic stroke, but not with lacunar stroke status." Stroke. 2013;44(6):1609-15.
Adib-Samii P, Rost N, Traylor M, et al. "17q25 Locus is associated with white matter hyperintensity volume in ischemic stroke, but not with lacunar stroke status." Stroke. 2013;44(6):1609-15.
Lu Y, Ballew SH, Tanaka H, Szklo M, Heiss G, Coresh JJ. "2017 ACC/AHA blood pressure classification and incident peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) Study." Eur J Prev Cardiol. 2020;27(1):51-59.
Michos ED, Selvin E, Misialek JR, et al. "25-Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study." J Am Heart Assoc. 2016;5(11).
van der Harst P, van Setten J, Verweij N, et al. "52 Genetic Loci Influencing Myocardial Mass." J Am Coll Cardiol. 2016;68(13):1435-1448.
van der Harst P, van Setten J, Verweij N, et al. "52 Genetic Loci Influencing Myocardial Mass." J Am Coll Cardiol. 2016;68(13):1435-1448.
van der Harst P, van Setten J, Verweij N, et al. "52 Genetic Loci Influencing Myocardial Mass." J Am Coll Cardiol. 2016;68(13):1435-1448.
van der Harst P, van Setten J, Verweij N, et al. "52 Genetic Loci Influencing Myocardial Mass." J Am Coll Cardiol. 2016;68(13):1435-1448.
van der Harst P, van Setten J, Verweij N, et al. "52 Genetic Loci Influencing Myocardial Mass." J Am Coll Cardiol. 2016;68(13):1435-1448.
van der Harst P, van Setten J, Verweij N, et al. "52 Genetic Loci Influencing Myocardial Mass." J Am Coll Cardiol. 2016;68(13):1435-1448.
van der Harst P, van Setten J, Verweij N, et al. "52 Genetic Loci Influencing Myocardial Mass." J Am Coll Cardiol. 2016;68(13):1435-1448.
van der Harst P, van Setten J, Verweij N, et al. "52 Genetic Loci Influencing Myocardial Mass." J Am Coll Cardiol. 2016;68(13):1435-1448.
Nambi V, Boerwinkle E, Lawson K, et al. "The 9p21 genetic variant is additive to carotid intima media thickness and plaque in improving coronary heart disease risk prediction in white participants of the Atherosclerosis Risk in Communities (ARIC) Study." Atherosclerosis. 2012;222(1):135-7.
Nambi V, Boerwinkle E, Lawson K, et al. "The 9p21 genetic variant is additive to carotid intima media thickness and plaque in improving coronary heart disease risk prediction in white participants of the Atherosclerosis Risk in Communities (ARIC) Study." Atherosclerosis. 2012;222(1):135-7.
Nambi V, Boerwinkle E, Lawson K, et al. "The 9p21 genetic variant is additive to carotid intima media thickness and plaque in improving coronary heart disease risk prediction in white participants of the Atherosclerosis Risk in Communities (ARIC) Study." Atherosclerosis. 2012;222(1):135-7.
Liu Y, Chen S, Li Z, Morrison AC, Boerwinkle E. "ACAT: A Fast and Powerful p Value Combination Method for Rare-Variant Analysis in Sequencing Studies." Am J Hum Genet. 2019;104(3):410-421.
Camplain R, Kucharska-Newton AMaria, Loehr LR, et al. "Accuracy of Self-Reported Heart Failure. The Atherosclerosis Risk in Communities (ARIC) Study." J Card Fail. 2017;23(11):802-808.
Amendola LM, Dorschner MO, Robertson PD, et al. "Actionable exomic incidental findings in 6503 participants: challenges of variant classification." Genome Res. 2015;25(3):305-15.
Amendola LM, Dorschner MO, Robertson PD, et al. "Actionable exomic incidental findings in 6503 participants: challenges of variant classification." Genome Res. 2015;25(3):305-15.
Amendola LM, Dorschner MO, Robertson PD, et al. "Actionable exomic incidental findings in 6503 participants: challenges of variant classification." Genome Res. 2015;25(3):305-15.
Amendola LM, Dorschner MO, Robertson PD, et al. "Actionable exomic incidental findings in 6503 participants: challenges of variant classification." Genome Res. 2015;25(3):305-15.
Amendola LM, Dorschner MO, Robertson PD, et al. "Actionable exomic incidental findings in 6503 participants: challenges of variant classification." Genome Res. 2015;25(3):305-15.
Amendola LM, Dorschner MO, Robertson PD, et al. "Actionable exomic incidental findings in 6503 participants: challenges of variant classification." Genome Res. 2015;25(3):305-15.
Amendola LM, Dorschner MO, Robertson PD, et al. "Actionable exomic incidental findings in 6503 participants: challenges of variant classification." Genome Res. 2015;25(3):305-15.
Amendola LM, Dorschner MO, Robertson PD, et al. "Actionable exomic incidental findings in 6503 participants: challenges of variant classification." Genome Res. 2015;25(3):305-15.
Amendola LM, Dorschner MO, Robertson PD, et al. "Actionable exomic incidental findings in 6503 participants: challenges of variant classification." Genome Res. 2015;25(3):305-15.
Howard G, Burke GL, Szklo M, et al. "Active and passive smoking are associated with increased carotid wall thickness. The Atherosclerosis Risk in Communities Study." Arch Intern Med. 1994;154(11):1277-82.
London SJ, Gao W, Gharib SA, et al. "ADAM19 and HTR4 variants and pulmonary function: Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium Targeted Sequencing Study." Circ Cardiovasc Genet. 2014;7(3):350-8.
Morrison AC, Bray MS, Folsom AR, Boerwinkle E. "ADD1 460W allele associated with cardiovascular disease in hypertensive individuals." Hypertension. 2002;39(6):1053-7.
Morrison AC, Bray MS, Folsom AR, Boerwinkle E. "ADD1 460W allele associated with cardiovascular disease in hypertensive individuals." Hypertension. 2002;39(6):1053-7.
Duncan BB, Schmidt M I, Pankow JS, et al. "Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study." Diabetes. 2004;53(9):2473-8.
Duncan BB, Schmidt M I, Pankow JS, et al. "Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study." Diabetes. 2004;53(9):2473-8.
Chang AR, Grams ME, Ballew SH, et al. "Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium." BMJ. 2019;364:k5301.
Chang AR, Grams ME, Ballew SH, et al. "Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium." BMJ. 2019;364:k5301.
Fernandes-Silva MM, Shah AM, Claggett B, et al. "Adiposity, body composition and ventricular-arterial stiffness in the elderly: the Atherosclerosis Risk in Communities Study." Eur J Heart Fail. 2018;20(8):1191-1201.
Cheng C-Y, Reich D, Coresh J, et al. "Admixture mapping of obesity-related traits in African Americans: the Atherosclerosis Risk in Communities (ARIC) Study." Obesity (Silver Spring). 2010;18(3):563-72.
Cheng C-Y, Reich D, Coresh J, et al. "Admixture mapping of obesity-related traits in African Americans: the Atherosclerosis Risk in Communities (ARIC) Study." Obesity (Silver Spring). 2010;18(3):563-72.
Cheng C-Y, Reich D, Wong TY, et al. "Admixture mapping scans identify a locus affecting retinal vascular caliber in hypertensive African Americans: the Atherosclerosis Risk in Communities (ARIC) study." PLoS Genet. 2010;6(4):e1000908.
Ferdinands JM, Mannino DM, Gwinn ML, Bray MS. "ADRB2 Arg16Gly polymorphism, lung function, and mortality: results from the Atherosclerosis Risk in Communities study." PLoS One. 2007;2(3):e289.
Beck JD, Philips K, Moss K, Divaris K, Morelli T. "Advances in precision oral health." Periodontol 2000. 2020;82(1):268-285.
Tandon A, Chen CJ, Penman A, et al. "African Ancestry Analysis and Admixture Genetic Mapping for Proliferative Diabetic Retinopathy in African Americans." Invest Ophthalmol Vis Sci. 2015;56(6):3999-4005.
Cheng C-Y, Reich D, Haiman CA, et al. "African ancestry and its correlation to type 2 diabetes in African Americans: a genetic admixture analysis in three U.S. population cohorts." PLoS One. 2012;7(3):e32840.
Cheng C-Y, Reich D, Haiman CA, et al. "African ancestry and its correlation to type 2 diabetes in African Americans: a genetic admixture analysis in three U.S. population cohorts." PLoS One. 2012;7(3):e32840.
M Gore O, Seliger SL, Defilippi CR, et al. "Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay." J Am Coll Cardiol. 2014;63(14):1441-8.
Liao D, Barnes RW, Chambless LE, Simpson RJ, Sorlie P, Heiss G. "Age, race, and sex differences in autonomic cardiac function measured by spectral analysis of heart rate variability--the ARIC study. Atherosclerosis Risk in Communities." Am J Cardiol. 1995;76(12):906-12.
Li J, Agarwal SK, Alonso A, et al. "Airflow obstruction, lung function, and incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study." Circulation. 2014;129(9):971-80.
Grams ME, Astor BC, Bash LD, Matsushita K, Wang Y, Coresh J. "Albuminuria and estimated glomerular filtration rate independently associate with acute kidney injury." J Am Soc Nephrol. 2010;21(10):1757-64.
Mok Y, Ballew SH, Stacey RBrandon, et al. "Albuminuria and Prognosis Among Individuals With Atherosclerotic Cardiovascular Disease: The ARIC Study." J Am Coll Cardiol. 2021;78(1):87-89.
Mok Y, Ballew SH, Sang Y, Coresh JJ, Joshu CE, Platz EA. "Albuminuria, Kidney Function, and Cancer Risk in the Community." Am J Epidemiol. 2020;189(9):942-950.
Oelsner EC, Balte PP, Grams ME, et al. "Albuminuria, Lung Function Decline, and Risk of Incident Chronic Obstructive Pulmonary Disease. The NHLBI Pooled Cohorts Study." Am J Respir Crit Care Med. 2019;199(3):321-332.
Oelsner EC, Balte PP, Grams ME, et al. "Albuminuria, Lung Function Decline, and Risk of Incident Chronic Obstructive Pulmonary Disease. The NHLBI Pooled Cohorts Study." Am J Respir Crit Care Med. 2019;199(3):321-332.
Oelsner EC, Balte PP, Grams ME, et al. "Albuminuria, Lung Function Decline, and Risk of Incident Chronic Obstructive Pulmonary Disease. The NHLBI Pooled Cohorts Study." Am J Respir Crit Care Med. 2019;199(3):321-332.
Lazo M, Chen Y, McEvoy JW, et al. "Alcohol Consumption and Cardiac Biomarkers: The Atherosclerosis Risk in Communities (ARIC) Study." Clin Chem. 2016;62(9):1202-10.
Kao WH, Puddey IB, Boland LL, Watson RL, Brancati FL. "Alcohol consumption and the risk of type 2 diabetes mellitus: atherosclerosis risk in communities study." Am J Epidemiol. 2001;154(8):748-57.
Kao WH, Puddey IB, Boland LL, Watson RL, Brancati FL. "Alcohol consumption and the risk of type 2 diabetes mellitus: atherosclerosis risk in communities study." Am J Epidemiol. 2001;154(8):748-57.
Demirovic J, Nabulsi A, Folsom AR, et al. "Alcohol consumption and ultrasonographically assessed carotid artery wall thickness and distensibility. The Atherosclerosis Risk in Communities (ARIC) Study Investigators." Circulation. 1993;88(6):2787-93.
Palmer ND, Kahali B, Kuppa A, et al. "Allele-specific variation at APOE increases nonalcoholic fatty liver disease and obesity but decreases risk of Alzheimer's disease and myocardial infarction." Hum Mol Genet. 2021;30(15):1443-1456.
Palmer ND, Kahali B, Kuppa A, et al. "Allele-specific variation at APOE increases nonalcoholic fatty liver disease and obesity but decreases risk of Alzheimer's disease and myocardial infarction." Hum Mol Genet. 2021;30(15):1443-1456.
Palmer ND, Kahali B, Kuppa A, et al. "Allele-specific variation at APOE increases nonalcoholic fatty liver disease and obesity but decreases risk of Alzheimer's disease and myocardial infarction." Hum Mol Genet. 2021;30(15):1443-1456.
Raffield LM, Iyengar AK, Wang B, et al. "Allelic Heterogeneity at the CRP Locus Identified by Whole-Genome Sequencing in Multi-ancestry Cohorts." Am J Hum Genet. 2020;106(1):112-120.
Raffield LM, Iyengar AK, Wang B, et al. "Allelic Heterogeneity at the CRP Locus Identified by Whole-Genome Sequencing in Multi-ancestry Cohorts." Am J Hum Genet. 2020;106(1):112-120.
Raffield LM, Iyengar AK, Wang B, et al. "Allelic Heterogeneity at the CRP Locus Identified by Whole-Genome Sequencing in Multi-ancestry Cohorts." Am J Hum Genet. 2020;106(1):112-120.
Beecham GW, Bis JC, Martin ER, et al. "The Alzheimer's Disease Sequencing Project: Study design and sample selection." Neurol Genet. 2017;3(5):e194.
Beecham GW, Bis JC, Martin ER, et al. "The Alzheimer's Disease Sequencing Project: Study design and sample selection." Neurol Genet. 2017;3(5):e194.
Beecham GW, Bis JC, Martin ER, et al. "The Alzheimer's Disease Sequencing Project: Study design and sample selection." Neurol Genet. 2017;3(5):e194.
Beecham GW, Bis JC, Martin ER, et al. "The Alzheimer's Disease Sequencing Project: Study design and sample selection." Neurol Genet. 2017;3(5):e194.
Mok Y, Sang Y, Ballew SH, et al. "American Heart Association's Life's Simple 7 at Middle Age and Prognosis After Myocardial Infarction in Later Life." J Am Heart Assoc. 2018;7(4).
C Quarta C, Buxbaum JN, Shah AM, et al. "The amyloidogenic V122I transthyretin variant in elderly black Americans." N Engl J Med. 2015;372(1):21-9.
C Quarta C, Buxbaum JN, Shah AM, et al. "The amyloidogenic V122I transthyretin variant in elderly black Americans." N Engl J Med. 2015;372(1):21-9.
C Quarta C, Buxbaum JN, Shah AM, et al. "The amyloidogenic V122I transthyretin variant in elderly black Americans." N Engl J Med. 2015;372(1):21-9.
Brody JA, Morrison AC, Bis JC, et al. "Analysis commons, a team approach to discovery in a big-data environment for genetic epidemiology." Nat Genet. 2017;49(11):1560-1563.
Brody JA, Morrison AC, Bis JC, et al. "Analysis commons, a team approach to discovery in a big-data environment for genetic epidemiology." Nat Genet. 2017;49(11):1560-1563.

Pages